242 related articles for article (PubMed ID: 22275254)
1. Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis.
Rossi S; Furlan R; De Chiara V; Motta C; Studer V; Mori F; Musella A; Bergami A; Muzio L; Bernardi G; Battistini L; Martino G; Centonze D
Ann Neurol; 2012 Jan; 71(1):76-83. PubMed ID: 22275254
[TBL] [Abstract][Full Text] [Related]
2. Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis.
Musumeci G; Grasselli G; Rossi S; De Chiara V; Musella A; Motta C; Studer V; Bernardi G; Haji N; Sepman H; Fresegna D; Maccarrone M; Mandolesi G; Centonze D
Neurobiol Dis; 2011 Sep; 43(3):669-77. PubMed ID: 21672630
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration.
Rossi S; Motta C; Studer V; Barbieri F; Buttari F; Bergami A; Sancesario G; Bernardini S; De Angelis G; Martino G; Furlan R; Centonze D
Mult Scler; 2014 Mar; 20(3):304-12. PubMed ID: 23886826
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53.
Rossi S; Motta C; Studer V; Macchiarulo G; Volpe E; Barbieri F; Ruocco G; Buttari F; Finardi A; Mancino R; Weiss S; Battistini L; Martino G; Furlan R; Drulovic J; Centonze D
Mol Neurodegener; 2014 Dec; 9():56. PubMed ID: 25495224
[TBL] [Abstract][Full Text] [Related]
5. Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis.
Rossi S; Mancino R; Bergami A; Mori F; Castelli M; De Chiara V; Studer V; Mataluni G; Sancesario G; Parisi V; Kusayanagi H; Bernardi G; Nucci C; Bernardini S; Martino G; Furlan R; Centonze D
Mult Scler; 2011 Nov; 17(11):1301-12. PubMed ID: 21677024
[TBL] [Abstract][Full Text] [Related]
6. RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis.
Mori F; Nisticò R; Nicoletti CG; Zagaglia S; Mandolesi G; Piccinin S; Martino G; Finardi A; Rossini PM; Marfia GA; Furlan R; Centonze D
Mult Scler; 2016 Oct; 22(11):1405-1412. PubMed ID: 26733422
[TBL] [Abstract][Full Text] [Related]
7. Inflammation inhibits GABA transmission in multiple sclerosis.
Rossi S; Studer V; Motta C; De Chiara V; Barbieri F; Bernardi G; Centonze D
Mult Scler; 2012 Nov; 18(11):1633-5. PubMed ID: 22419673
[TBL] [Abstract][Full Text] [Related]
8. Chronic LPS exposure produces changes in intrinsic membrane properties and a sustained IL-beta-dependent increase in GABAergic inhibition in hippocampal CA1 pyramidal neurons.
Hellstrom IC; Danik M; Luheshi GN; Williams S
Hippocampus; 2005; 15(5):656-64. PubMed ID: 15889405
[TBL] [Abstract][Full Text] [Related]
9. Metabotropic glutamate receptors modulate glutamatergic and GABAergic synaptic transmission in the central nucleus of the inferior colliculus.
Farazifard R; Wu SH
Brain Res; 2010 Apr; 1325():28-40. PubMed ID: 20153735
[TBL] [Abstract][Full Text] [Related]
10. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.
Mandolesi G; De Vito F; Musella A; Gentile A; Bullitta S; Fresegna D; Sepman H; Di Sanza C; Haji N; Mori F; Buttari F; Perlas E; Ciotti MT; Hornstein E; Bozzoni I; Presutti C; Centonze D
J Neurosci; 2017 Jan; 37(3):546-561. PubMed ID: 28100738
[TBL] [Abstract][Full Text] [Related]
11. Chronic BDNF deficiency permanently modifies excitatory synapses in the piriform cortex.
Nanobashvili A; Jakubs K; Kokaia M
J Neurosci Res; 2005 Sep; 81(5):696-705. PubMed ID: 16035106
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1β Alters Hebbian Synaptic Plasticity in Multiple Sclerosis.
Stampanoni Bassi M; Buttari F; Nicoletti CG; Mori F; Gilio L; Simonelli I; De Paolis N; Marfia GA; Furlan R; Finardi A; Centonze D; Iezzi E
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977401
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis.
Mandolesi G; Musella A; Gentile A; Grasselli G; Haji N; Sepman H; Fresegna D; Bullitta S; De Vito F; Musumeci G; Di Sanza C; Strata P; Centonze D
J Neurosci; 2013 Jul; 33(29):12105-21. PubMed ID: 23864696
[TBL] [Abstract][Full Text] [Related]
14. [Role of glutamate transporters in excitatory synapses in cerebellar Purkinje cells].
Ozawa S
Brain Nerve; 2007 Jul; 59(7):669-76. PubMed ID: 17663137
[TBL] [Abstract][Full Text] [Related]
15. Dual modulation of synaptic transmission in the nucleus tractus solitarius by prostaglandin E2 synthesized downstream of IL-1beta.
Marty V; El Hachmane M; Amédée T
Eur J Neurosci; 2008 Jun; 27(12):3132-50. PubMed ID: 18598258
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients.
Wen SR; Liu GJ; Feng RN; Gong FC; Zhong H; Duan SR; Bi S
J Neuroimmunol; 2012 Mar; 244(1-2):94-6. PubMed ID: 22329905
[TBL] [Abstract][Full Text] [Related]
17. Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid.
Sarchielli P; Greco L; Floridi A; Floridi A; Gallai V
Arch Neurol; 2003 Aug; 60(8):1082-8. PubMed ID: 12925363
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1beta induces hyperpolarization and modulates synaptic inhibition in preoptic and anterior hypothalamic neurons.
Tabarean IV; Korn H; Bartfai T
Neuroscience; 2006 Sep; 141(4):1685-95. PubMed ID: 16777343
[TBL] [Abstract][Full Text] [Related]
19. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.
Vercellino M; Merola A; Piacentino C; Votta B; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
J Neuropathol Exp Neurol; 2007 Aug; 66(8):732-9. PubMed ID: 17882017
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-18 stimulates synaptically released glutamate and enhances postsynaptic AMPA receptor responses in the CA1 region of mouse hippocampal slices.
Kanno T; Nagata T; Yamamoto S; Okamura H; Nishizaki T
Brain Res; 2004 Jun; 1012(1-2):190-3. PubMed ID: 15158178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
